GILEAD SCIENCES, INC.

(GILD)
  Report
Delayed Nasdaq  -  05/26 04:00:00 pm EDT
64.47 USD   -0.83%
05/23WALL STREET STOCK EXCHANGE : Biden comments reassure investors
05/23SVB Securities Initiates Gilead Sciences at Market Perform With $68 Price Target
MT
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Gilead Sciences, Inc.
Gilead Sciences, Inc. specializes in the development, manufacturing and marketing of therapeutic products. Net sales break down by source of income as follows:

- sale of drugs (98.9%): for the treatment of HIV (50% of net sales), COVID-19 (7.4%), hepatitis C virus (4%), hepatitis B virus (1.4%) and other (37.2%; primarily cytomegalovirus retinitis, and advanced Kaposi sarcoma resulting from HIV);

- other (1.3%): especially royalties and revenue from research and development services and from subcontracted production of therapeutic products.

Net sales are distributed geographically as follows: the United States (70.6%), Europe (17.8%) and other (11.6%).

Number of employees : 14 400 people.
Sales per Business
20202021Delta
Innovative Medicines24 689.00100%27 305.00100% +10.6%
USD in Million
Sales per region
20202021Delta
United States18 217.0073.8%19 267.0070.6% +5.76%
Europe4 135.0016.7%4 874.0017.9% +17.87%
Other International2 337.009.5%3 164.0011.6% +35.39%
USD in Million
Managers
Name Title Age Since
Daniel O'Day Chairman & Chief Executive Officer 56 2019
Andrew Dickinson Chief Financial Officer 51 2019
Merdad Parsey Chief Medical Officer 57 2019
Flavius Martin Executive Vice President-Research - 2021
Brett Pletcher Secretary, Chief Compliance Officer & Executive VP 54 -
Jacquie Ross Investor Relations Contact - 2021
Taiyin Yang, Dr. EVP-Pharmaceutical Development & Manufacturing 67 2015
Johanna Mercier Chief Commercial Officer 51 2019
Tomas Cihlar, Dr. Vice President-Virology - -
Linda Slanec Higgins, Dr. Senior VP-Research & External Innovation 58 2010
Members of the board
Name Title Age Since
Daniel O'Day Chairman & Chief Executive Officer 56 2019
Kevin E. Lofton Lead Independent Director 66 2020
Kelly A. Kramer Independent Director 53 2016
Jacqueline K. Barton, Dr. Independent Director 68 2018
Harish M. Manwani Independent Director 67 2018
Sandra J. Horning, Dr. Independent Director 72 2020
Javier Rodriguez Independent Director 50 2020
Anthony Welters Independent Director 66 2020
Jeffrey A. Bluestone, Dr. Independent Director 67 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,254,313,448 1,253,513,224 99.9% 0 0.0% 99.9%
Shareholders
NameEquities%
The Vanguard Group, Inc. 100,472,614 8.00%
Capital Research & Management Co. 64,780,000 5.16%
SSgA Funds Management, Inc. 57,970,959 4.62%
Capital Research & Management Co. (Global Investors) 55,951,379 4.46%
Capital Research & Management Co. (World Investors) 49,501,852 3.94%
Dodge & Cox 37,026,630 2.95%
BlackRock Fund Advisors 28,319,140 2.26%
Geode Capital Management LLC 22,703,667 1.81%
Arrowstreet Capital LP 18,002,214 1.43%
Renaissance Technologies LLC 15,492,116 1.23%
Holdings
NameEquities%Valuation
GALAPAGOS NV (GLPG) 16,707,477 25.5% 987,030,960 USD
ARCUS BIOSCIENCES, INC. (RCUS) 13,913,029 19.4% 336,834,432 USD
SIERRA ONCOLOGY, INC. (SRRA) 725,283 3.03% 39,535,176 USD
TANGO THERAPEUTICS, INC. (TNGX) 4,852,550 5.53% 35,714,768 USD
JOUNCE THERAPEUTICS, INC. (JNCE) 5,539,727 10.7% 29,360,553 USD
AGENUS INC. (AGEN) 11,111,111 4.32% 20,555,555 USD
ALLOGENE THERAPEUTICS, INC. (ALLO) 1,156,689 0.81% 9,658,353 USD
HOOKIPA PHARMA INC. (HOOK) 3,759,465 7.39% 5,639,198 USD
Markets and indexes
- Nasdaq Global Select Market
- Nasdaq 100 / S&P 100, S&P 500, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  GILD:US
- Reuters Code :  GILD.O
- Datastream Code :  
Company contact information
Gilead Sciences, Inc.
333 Lakeside Drive
CA 94404 San Mateo, California

Phone : +1 650 574 3000
Fax : +1 650 578 9264
web site : http://www.gilead.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Gilead Sciences, Inc.